Single-dose eculizumab as part of a modified desensitization protocol for ABO-incompatible living donor liver
Mario Spaggiari1, Egor Petrochenkov1, Giulia Bencini1
1Division of Transplantation, Department of Surgery, University of Illinois at Chicago, Chicago, Illinois, USA.
Abstract
No abstract available in PubMed .


